Abstract B81: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to the cyclin-dependent kinase 2 inhibitor dinaciclib.

2016 ◽  
Author(s):  
Andrew J. Wilson ◽  
Jeanette Saskowski ◽  
Dineo Khabele
Keyword(s):  
Ovarian Cancer ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Cyclin E ◽  
Ovarian Cancer Cells ◽  
Cyclin Dependent Kinase ◽  
Deacetylase Inhibitor

scholarly journals The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells

2016 ◽  
Vol 36 (11) ◽  
pp. 5731-5742 ◽  
Author(s):  
KAROLINA LAPINSKA ◽  
GENEVIEVE HOUSMAN ◽  
SHANNON BYLER ◽  
SARAH HEERBOTH ◽  
AMBER WILLBANKS ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Ovarian Cancer Cells ◽  
Calpain Inhibitor ◽  
Combination Therapies ◽  
Deacetylase Inhibitor ◽  
Inhibitor Combination
Sign in / Sign up

Export Citation Format

Share Document